ANASPAZ
- Product NDC
- 0225-0295
- 11-digit product format
- 002250295
- Labeler code
- 0225
- Product ID
- 0225-0295_5b5d2c46-5cd4-c6ef-e053-2991aa0adf32
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- HYOSCYAMINE SULFATE
- Dosage form
- TABLET, ORALLY DISINTEGRATING
- Route
- ORAL; SUBLINGUAL
- Labeler
- BF ASCHER AND CO INC
- Marketing category
- UNAPPROVED DRUG OTHER
- Marketing start
- 1973-01-02
- Marketing end
- 0000-00-00
- Substance
- HYOSCYAMINE SULFATE
- Active strength
- 0 mg/1
- NDC exclude flag
- No
- Listing certified through
- 2020-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| HYOSCYAMINE SULFATE | ACTIVE INGREDIENT | F2R8V82B84 | ANASPAZ (HYOSCYAMINE SULFATE) TABLET, ORALLY DISINTEGRATING [BF ASCHER AND CO INC] | 2 | |
| HYOSCYAMINE | ACTIVE MOIETY | PX44XO846X | ANASPAZ (HYOSCYAMINE SULFATE) TABLET, ORALLY DISINTEGRATING [BF ASCHER AND CO INC] | 2 | |
| D&C YELLOW NO. 10 | INACTIVE INGREDIENT | 35SW5USQ3G | ANASPAZ (HYOSCYAMINE SULFATE) TABLET, ORALLY DISINTEGRATING [BF ASCHER AND CO INC] | 2 | |
| FD&C YELLOW NO. 6 | INACTIVE INGREDIENT | H77VEI93A8 | ANASPAZ (HYOSCYAMINE SULFATE) TABLET, ORALLY DISINTEGRATING [BF ASCHER AND CO INC] | 2 | |
| LACTOSE | INACTIVE INGREDIENT | J2B2A4N98G | ANASPAZ (HYOSCYAMINE SULFATE) TABLET, ORALLY DISINTEGRATING [BF ASCHER AND CO INC] | 2 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | ANASPAZ (HYOSCYAMINE SULFATE) TABLET, ORALLY DISINTEGRATING [BF ASCHER AND CO INC] | 2 | |
| MANNITOL | INACTIVE INGREDIENT | 3OWL53L36A | ANASPAZ (HYOSCYAMINE SULFATE) TABLET, ORALLY DISINTEGRATING [BF ASCHER AND CO INC] | 2 | |
| SORBITOL | INACTIVE INGREDIENT | 506T60A25R | ANASPAZ (HYOSCYAMINE SULFATE) TABLET, ORALLY DISINTEGRATING [BF ASCHER AND CO INC] | 2 | |
| STARCH, CORN | INACTIVE INGREDIENT | O8232NY3SJ | ANASPAZ (HYOSCYAMINE SULFATE) TABLET, ORALLY DISINTEGRATING [BF ASCHER AND CO INC] | 2 | |
| STEARIC ACID | INACTIVE INGREDIENT | 4ELV7Z65AP | ANASPAZ (HYOSCYAMINE SULFATE) TABLET, ORALLY DISINTEGRATING [BF ASCHER AND CO INC] | 2 | |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 0225-0295 | ANASPAZ (HYOSCYAMINE SULFATE) TABLET, ORALLY DISINTEGRATING [BF ASCHER AND CO INC] | 4 | Legacy NDC | 20240726_e5fd8476-418a-4149-a688-205ea943b30c.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 0225-0295-15 | 00225029515 | 100 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE, PLASTIC (0225-0295-15) | 1973-01-02 | 0000-00-00 | No | No | Current |
| 0225-0295-20 | 00225029520 | 500 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE, PLASTIC (0225-0295-20) | 1973-01-02 | 0000-00-00 | No | No | Current |